Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.67 |
| ▸ | CA9 | Q16790 | 2/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.40 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.40 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL179201 | 1.00 | CA1 (0.67) | CA1CA9SMN1; SMN2KMT2ACA2 | |
| SCHEMBL3903307 | 1.00 | CA1 (0.67) | CA1CA9SMN1; SMN2KMT2ACA2 | |
| SCHEMBL15660000 | 1.00 | CA1 (0.67) | CA1CA9SMN1; SMN2KMT2ACA2 | |
| SCHEMBL15656167 | 1.00 | CA1 (0.67) | CA1CA9SMN1; SMN2KMT2ACA2 | |
| SCHEMBL3082261 | 1.00 | CA1 (0.67) | CA1CA9SMN1; SMN2KMT2ACA2 | |
| SCHEMBL24668102 | 1.00 | CA1 (0.67) | CA1CA9SMN1; SMN2KMT2ACA2 | |
| SCHEMBL3090419 | 1.00 | CA1 (0.67) | CA1CA9SMN1; SMN2KMT2ACA2 | |
| SCHEMBL3075568 | 1.00 | CA1 (0.67) | CA1CA9SMN1; SMN2KMT2ACA2 | |
| SCHEMBL12950185 | 1.00 | CA1 (0.67) | CA1CA9SMN1; SMN2KMT2ACA2 | |
| SCHEMBL11697947 | 1.00 | CA1 (0.67) | CA1CA9SMN1; SMN2KMT2ACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230332071-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP. | 2023-10-19 | — | — | US | disclosed |
| US-20230332071-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP. | 2023-10-19 | — | — | US | disclosed |
| US-20230332071-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP. | 2023-10-19 | — | — | US | disclosed |
| US-20230323244-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230323244-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230323244-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP (US) | 2023-10-12 | — | — | US | disclosed |
| US-11639483-B2 | Macrocyclic musk lactones and uses thereof | PHYTO TECH CORP. (US) | 2023-05-02 | — | — | US | disclosed |
| US-11639483-B2 | Macrocyclic musk lactones and uses thereof | PHYTO TECH CORP. (US) | 2023-05-02 | — | — | US | disclosed |
| US-11639483-B2 | Macrocyclic musk lactones and uses thereof | PHYTO TECH CORP. (US) | 2023-05-02 | — | — | US | disclosed |
| US-20220298451-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP. | 2022-09-22 | — | — | US | disclosed |
| US-20220298451-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP. | 2022-09-22 | — | — | US | disclosed |
| WO-2022192384-A1 | BIOSYNTHETIC PRODUCTION OF MACROCYCLIC MUSK LACTONES FROM FATTY ACIDS | CONAGEN INC. (US) | 2022-09-15 | — | — | WO | disclosed |
| US-8383834-B2 | Process for preparing unsaturated lactones | SYMRISE AG (DE) | 2013-02-26 | — | — | US | disclosed |
| US-20090306411-A1 | PROCESS FOR PREPARING UNSATURATED LACTONES | SYMRISE GMBH & CO. KG (DE) | 2009-12-10 | — | — | US | disclosed |
| WO-2005113533-A9 | PROCESS FOR PREPARING UNSATURATED LACTONES | SYMRISE GMBH & CO. KG (DE) | 2009-09-24 | — | — | WO | disclosed |
| EP-1747211-B1 | PROCESS FOR PREPARING UNSATURATED LACTONES | SYMRISE GMBH & CO KG (DE) | 2009-08-26 | — | — | EP | disclosed |
| EP-1747211-A1 | PROCESS FOR PREPARING UNSATURATED LACTONES | Akzo Nobel N.V. (NL) | 2007-01-31 | — | — | EP | disclosed |
| WO-2005113533-A1 | PROCESS FOR PREPARING UNSATURATED LACTONES | SYMRISE GMBH & CO. KG (DE) | 2005-12-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11639483-B2 | Macrocyclic musk lactones and uses thereof | MGLL, UGCG, DAGLA | CA1 4782/4885CA9 4512/4885SMN1; SMN2 2700/4885 |
| US-20230323244-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | MGLL, UGCG, DAGLA | CA1 4782/4885CA9 4512/4885SMN1; SMN2 2700/4885 |
| US-20090306411-A1 | PROCESS FOR PREPARING UNSATURATED LACTONES | ALOX5, ALOX12, ALOX15 | CA1 535/4885CA9 2439/4885SMN1; SMN2 4604/4885 |
| US-20220298451-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | MGLL, UGCG, DAGLA | CA1 4782/4885CA9 4512/4885SMN1; SMN2 2700/4885 |
| US-20230332071-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | MGLL, UGCG, DAGLA | CA1 4782/4885CA9 4512/4885SMN1; SMN2 2700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.